15-12B 1 tm2035362d1_1512b.htm FORM 15-12B

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

 

 

FORM 15

 

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION
OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number: 001-38983

 

 

 

LIVONGO HEALTH, INC.

(Exact name of registrant as specified in its charter)

 

 

 

150 West Evelyn Avenue, Suite 150

Mountain View, California 94041

(866) 435-5643

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock, $0.001 Par Value
(Title of class of securities covered by this Form)

 

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1) x
Rule 12g-4(a)(2) ¨
Rule 12h-3(b)(1)(i) x
Rule 12h-3(b)(1)(ii) ¨
Rule 15d-6 ¨
Rule 15d-22(b) ¨

 

Approximate number of holders of record as of the certification or notice date: One (1)

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Livongo Health, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

  LIVONGO HEALTH, INC.
   
   
Date:  November 9, 2020 By:  /s/ Adam C. Vandervoort
  Name: Adam C. Vandervoort
  Title: President